Australian
Society for Medical
Entrepreneurship
& Innovation
ASME, home
All resources
Playbook7 min26 Feb 2026

Four equity questions before you sign a clinician advisor agreement

The FAST template's standard terms. The ESS Startup Concession's eligibility window. Australian restraint case law. The four checks every clinician advisor should run before they sign.

By ASME Editorial

Playbook

The advisor decision is a tax decision

A founder messages you on LinkedIn. They are clinical, you are clinical, the company solves a real problem. Would you advise? They will pay you in equity. Most clinicians say yes without confirming the four things that determine whether the equity is worth anything in three years, and at least two of those things are tax structure rather than compensation.

The Australian context is specific. Advisor equity is usually structured as options under an Employee Share Scheme. The default tax treatment under section 83A-110 of the Income Tax Assessment Act produces a taxable benefit at grant in many cases, payable against an asset you cannot sell. The ESS Startup Concession (section 83A-33) defers that tax to disposal but requires the company to qualify. The first question is therefore not how much equity, but under what tax framework.

Question one: vesting schedule

The Founder Institute's Founder Advisor Standard Template (FAST), the reference template for advisor agreements globally, vests advisor equity over two years on a monthly schedule with a three-month cliff. Per the FAST published terms, the cliff exists so that an unproductive relationship can be terminated without allocating any equity in the first three months. After the cliff, equity vests monthly.

Schedules that diverge from FAST defaults are signals. A four-year schedule with a one-year cliff is the employee schedule and is not appropriate for an advisor. A 100 percent at the end of three years schedule is back-loaded and either reflects a founder unfamiliar with standard terms, or, less charitably, an intent to terminate the relationship just before the grant vests.

Counter-offer if the schedule is back-loaded. Two-year monthly vesting with a three-month cliff. If the founder pushes back without a coherent reason, the answer tells you whether the founder has done a single advisor agreement before.

Question two: ESS eligibility and the strike price

Per section 83A-33 of the Income Tax Assessment Act 1997, the ESS Startup Concession applies only to companies that are unlisted, less than ten years old, and have aggregated turnover under A$50 million in the previous income year. The discount on shares is capped at 15 percent of market value. Options must have a strike price at or above the market value of an ordinary share at grant.

Ask the founder. Has the company been structured to qualify for the Startup Concession? What is the strike price? What was the most recent valuation, and which valuation method (NTA or arm's length) supports the strike price? If the founder cannot answer in five minutes, the legal work has not been done, and you do not want to be the test case.

If the company does not qualify for the Startup Concession, the structure should be reviewed by your accountant before you sign. Phantom equity, deferred-tax arrangements, or a different security class are workable alternatives, but they need to be set up by someone who has done it before.

Question three: change-of-control acceleration

The likely outcome of an early-stage company is acquisition rather than IPO. Without acceleration, an advisor whose equity has only partly vested at acquisition walks away with a fraction of the promised grant. The acquirer often terminates the advisory relationship after close because they bring in their own clinical advisors, so the worst case is the realistic case.

Ask for double-trigger acceleration. 100 percent of unvested equity vests on a change of control plus termination of the advisory relationship. This is the standard ask for senior employees and is reasonable for active advisors. If the founder will not give double-trigger, ask for at least 50 percent acceleration on change of control alone.

Question four: what does advisor actually mean

Advisor is not a defined role. The FAST template defines four engagement levels and recommends equity bands accordingly. For an early-stage startup at the time of writing: 0.25 percent for an advisory level (occasional intros and document review), 0.5 percent for standard engagement (monthly call, customer intros), 1 percent for an expert level (monthly meeting plus active recruiting and customer calls). For growth-stage companies, the same engagement levels are compensated at lower percentages.

Match the equity to the load. Document the engagement level in the agreement. Renegotiate at six months if the relationship has grown into something different. The founders who respect this conversation are the founders worth advising. The ones who do not are the ones whose equity will not vest anyway.

Final note for Australian advisors: amend the standard FAST template to reference the ESS Startup Concession explicitly where the company qualifies, and replace the default arbitration clause with a clean Australian forum (NSW or Victorian Supreme Court). The FAST template is good, but it is drafted for US incorporation by default.

Sources

  1. 01Founder Institute, FAST agreement (template and documentation)
  2. 02Founder Institute, The FAST agreement explained
  3. 03AustLII, Income Tax Assessment Act 1997 s 83A-33 (start-up concession)
  4. 04ATO, Employee share schemes: start-up companies (standard documents)
  5. 05BlueRock, ESS Start-up Concessions in Action: Case Study

Written by ASME Editorial · Published 26 Feb 2026